Abstract:Surgical site infection (SSI) is a common type of hospital‐acquired infection and affects up to a third of patients following surgical procedures. It is associated with significant mortality and morbidity. In the United Kingdom alone, it is estimated to add another £30 million to the cost of adult cardiac surgery. Although generic guidance for SSI prevention exists, this is not specific to adult cardiac surgery. Furthermore, many of the risk factors for SSI are prevalent within the cardiac surgery population. Despite this, there is currently no standard of care for SSI prevention in adults undergoing cardiac surgery throughout the preoperative, intraoperative and postoperative periods of care, with variations in practice existing throughout from risk stratification, decontamination strategies and surveillance. Primary objective: to assess the clinical effectiveness of pre‐, intra‐, and postoperative interventions in the prevention of cardiac SSI. Secondary objectives: (i) to evaluate the effects of SSI prevention interventions on morbidity, mortality, and resource use; (ii) to evaluate the effects of SSI prevention care bundles on morbidity, mortality, and resource use. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, MEDLINE (Ovid, from inception) and Embase (Ovid, from inception) on 31 May 2021. ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) were also searched for ongoing or unpublished trials on 21 May 2021. No language restrictions were imposed. We included RCTs evaluating interventions to reduce SSI in adults (≥ 18 years of age) who have undergone any cardiac surgery. We followed the methods as per our published Cochrane protocol. Our primary outcome was surgical site infection. Our secondary outcomes were all‐cause mortality, reoperation for SSI, hospital length of stay, hospital readmissions for SSI, healthcare costs and cost‐effectiveness, quality of life (QoL), and adverse effects. We used the GRADE approach to assess the certainty of evidence. A total of 118 studies involving 51,854 participants were included. Twenty‐two interventions to reduce SSI in adults undergoing cardiac surgery were identified. The risk of bias was judged to be high in the majority of studies. There was heterogeneity in the study populations and interventions; consequently, meta‐analysis was not appropriate for many of the comparisons and these are presented as narrative summaries. We focused our reporting of findings on four comparisons deemed to be of great clinical relevance by all review authors. Decolonisation versus no decolonisation Pooled data from three studies (n = 1564) using preoperative topical oral/nasal decontamination in all patients demonstrated an uncertain direction of treatment effect in relation to total SSI (RR 0.98, 95% CI 0.70 to 1.36; I 2 = 0%; very low‐certainty evidence). A single study reported that decolonisation likely results in little to no difference in superficial SSI (RR 1.35, 95% CI 0.84 to 2.15; moderate‐certainty evidence) and a reduction in deep SSI (RR 0.36, 95% CI 0.17 to 0.77; high‐certainty evidence). The evidence on all‐cause mortality from three studies (n = 1564) is very uncertain (RR 0.66, 95% CI 0.24 to 1.84; I 2 = 49%; very low‐certainty evidence). A single study (n = 954) demonstrated that decolonisation may result in little to no difference in hospital readmission for SSI (RR 0.80, 95% CI 0.44 to 1.45; low‐certainty evidence). A single study (n = 954) reported one case of temporary discolouration of teeth in the decolonisation arm (low‐certainty‐evidence. Reoperation for SSI was not reported. Tight glucose control versus standard glucose control Pooled data from seven studies (n = 880) showed that tight glucose control may reduce total SSI, but the evidence is very uncertain (RR 0.41, 95% CI 0.19 to 0.85; I 2 = 29%; numbers need to treat to benefit (NNTB) = 13; very‐low certainty evidence). Pooled data from seven studies (n = 3334) showed tight glucose control may reduce all‐cause mortality, but the evidence is very uncertain (RR 0.61, 95% CI 0.41 to 0.91; I 2 = 0%; very low‐certainty evidence). Based on four studies (n = 2793), there may be little to no difference in episodes of hypoglycaemia between tight control vs. standard control, but the evidence is very uncertain (RR 2.12, 95% CI 0.51 to 8.76; I 2 = 72%; very low‐certainty evidence). No studies reported superficial/deep SSI, reoperation for SSI, or hospital readmission for SSI. Negative pressure wound therapy (NPWT) versus standard dressings NPWT was assessed in two studies (n = 144) and it may reduce total SSI, but the evidence is very uncertain (RR 0.17, 95% CI 0.03 to 0.97; I 2 = 0%; NNTB = 10; very low‐certainty evidence). A single study (n = 80) reported reoperation for SSI. T -Abstract Truncated-

Randomized Controlled Trial: Does the Use of Occlusive Hydrocolloid Silver-Containing Wound Dressing after Sternotomy Reduce Surgical Site Infection after Cardiac Surgery?

Do Antibacterial Skin Sutures Reduce Surgical Site Infections After Elective Open Abdominal Surgery?—A Prospective, Randomized Controlled Single-Center Trial

Interventions to prevent surgical site infection in adults undergoing cardiac surgery

Early Post-Operative Water Exposure Does Not Increase Complications in Cutaneous Surgeries: A Randomized, Investigator-Blinded, Controlled Trial

Prevalence and predictors of surgical site infections after bowel resection for Crohn’s disease: the role of dual-ring wound protector

Evaluation of Negative Pressure Dressings for Closed Surgical Incisions in Decreasing Surgical Site Infections After Emergency Laparotomy: A Randomized Controlled Study

A Feasibility Survey to Inform Trial Design Investigating Surgical Site Infection Prevention in Vascular Surgery

Comparison of sterile polyacrylate wound dressing with activated carbon cloth and a standard non-adhesive hydrocellular foam dressing with silver: a randomised controlled trial protocol

To close or not to close? Wound management in emergent colorectal surgery, an EAST Multicenter prospective cohort study

Plastic Wound Protector vs Surgical Gauze for Surgical Site Infection Reduction in Open GI Surgery

A Comparison of Incisional Dressings and Negative-Pressure Wound Therapy for the Prevention of Infection and Wound Complications After Primary Total Hip and Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials

Systematic Review and Meta-Analysis of Triclosan-Coated Sutures for the Prevention of Surgical-Site Infection

A Vascular Multi‐arm Multi‐stage Trial to Prevent Groin Wound Surgical Site Infection: A Feasibility Survey

Superiority of a Silk Surgical Site Wound Closure Device Over Synthetic Dressings

Antimicrobial-coated Sutures Versus Non-Coated Sutures in Reducing Surgical Site Infection: an Updated Systematic Review and Meta-Analysis

Intraoperative Wound Irrigation for the Prevention of Surgical Site Infection After Laparotomy

Simplified dressing change after surgery for high anal fistula: A prospective, single centre randomized controlled study on loose combined cutting seton (LCCS) technique

Comparison of surgical site infection (SSI) between negative pressure wound therapy (NPWT) assisted delayed primary closure and conventional delayed primary closure in grossly contaminated emergency abdominal surgeries: a randomized controlled trial

Antimicrobial-coated Sutures to Decrease Surgical Site Infections: a Systematic Review and Meta-Analysis

Reducing Sternal Wound Infection Rates in Patients Undergoing Cardiothoracic Surgery with Sternotomy

Study To Reduce Infection Prior to Elective Cesarean Deliveries (STRIPES): a randomized clinical trial of chlorhexidine